M3OMG: has antidepressant activity
ID Source | ID |
---|---|
PubMed CID | 99622 |
CHEMBL ID | 1933687 |
SCHEMBL ID | 1465618 |
MeSH ID | M0077922 |
Synonym |
---|
3934-86-9 |
methyl 3-o-methyl gallate |
nsc-251664 |
nsc251664 |
m3omg |
methyl 3,4-dihydroxy-5-methoxybenzoate |
FT-0690169 |
benzoic acid, 3,4-dihydroxy-5-methoxy-, methyl ester |
A24318 |
AKOS005254586 |
3,4-dihydroxy-5-methoxybenzoic acid methyl ester |
SCHEMBL1465618 |
nsc 251664 |
methyl-o-methylgallate |
8fix3oq9g8 , |
unii-8fix3oq9g8 |
CHEMBL1933687 |
methyl 3,4-dihydroxy-5-methoxy-benzoate |
LVVUKXKEXOTUPV-UHFFFAOYSA-N |
methyl 3-methoxy-4,5-dihydroxybenzoate |
methyl 5-methoxy-3,4-dihydroxybenzoate |
W-200339 |
AC-22905 |
DTXSID70192562 |
mfcd00183269 |
CS-0036473 |
BBL103587 |
STL557397 |
AS-37642 |
3-methoxy-4,5-dihydroxybenzoic acid methyl ester |
methyl 4,5-dihydroxy-3-methoxybenzoate |
methyl 3-o-methylgallate |
protocatechuic acid, 5-methoxy-, methyl ester |
methyl3,4-dihydroxy-5-methoxybenzoate |
HY-N6669 |
Excerpt | Reference | Relevance |
---|---|---|
"M3OMG treatment mitigated the NaF-induced oxidative stress through normalization of the level of TBARS, reduced levels of glutathione and by the restoration of the diminished antioxidant enzyme activities." | ( Neuroprotective effects of methyl-3-O-methyl gallate against sodium fluoride-induced oxidative stress in the brain of rats. Habtemariam, S; Mirzaei, M; Moghaddam, AH; Nabavi, SF; Nabavi, SM; Sureda, A, 2013) | 1.11 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID638442 | Inhibition of yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 10 mins before substrate addition measured after 5 mins by micro-plate reader analysis | 2012 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1 | Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems. |
AID638443 | Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins | 2012 | Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1 | Maplexins, new α-glucosidase inhibitors from red maple (Acer rubrum) stems. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.38) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |